The Business Research Company’s Gene Therapy Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Gene Therapy Global Market Report 2023 evaluates gene therapy market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=9875&type=smp
The global gene therapy market is expected to grow from $24,027.1 million in 2027 at a rate of 26.7%. The market is then expected to grow at a CAGR of 13.4% from 2027 and reach $45,071.9 million in 2032.
Increasing number of cancer cases is expected to drive the growth of the gene therapy market during the forecast period. Cancer gene therapy is an emerging field using genetic material to modify cells in vitro or in vivo to help effect a cure. In gene therapy, a therapeutic human-designed new gene (transgene) was used to introduce to a subpopulation of human cells, such as human stem cells. For a cancer cell, the transgene can assist cell death or restore normal cellular functions, whereas for normal cells the transgene can protect them from drug-induced side effects and/or cytotoxicity. For example, according to the American Cancer Society, a US-based voluntary health organization, a total of 1.9 million new cancer cases and 609,360 deaths from cancer were expected to occur in the USA in 2022, which is about 1,670 deaths a day. Additionally, according to the International Agency for Research on Cancer, a France-based intergovernmental agency, by 2040, the number of new cancer cases per year globally is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Therefore, the increase in the number of cases of cancer is expected to contribute to the growth of the gene therapy market going forward.
Get More Information On The Gene Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/gene-therapy-market
The gene therapy market segments in the report are:
1) By Gene Therapy Type: Germline Therapy; Somatic Cell Therapy
2) By Vector: Viral Vector; Non-Viral Vector
3) By End Users: Biopharmaceutical Companies; Research Institutes; Other End Users
4) By Application: Oncology; Orphan Disease; Knee Osteoarthritis; Neurological Disorders
The table of contents in TBRC’s gene therapy market report includes:
- Executive Summary
- Table Of Contents
- List Of Figures
- List Of Tables
- Report Structure
.
.
.
- Key Mergers And Acquisitions
- Pipeline Analysis
- Opportunities And Strategies
- Gene Therapy Market, Conclusions And Recommendations
- Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
